Agree To Purchase Align Technology At $125, Earn 9.6% Using Options

Selling the January 2028 $125 put on Align Technology (ALGN) would net a $12 premium (implying a $113 cost basis if assigned) and is advertised as a ~5% annualized return; the trade only results in share ownership if ALGN falls ~32.1% from the current price of $184.34. Trailing twelve‑month volatility is ~60% (based on 251 trading days plus today), and intraday options flow shows a put:call ratio of 0.73 versus a long‑term median of 0.65, indicating slightly heavier put buying activity. The writeup frames the position as premium collection with downside assignment risk rather than participation in upside appreciation.

Analysis

Market structure: The options flow (put:call 0.73 vs median 0.65) and 60% trailing volatility signal elevated hedging/speculation in ALGN rather than broad sector stress. Put buyers (protection/speculators) benefit if ALGN drops >32% (current $184 → $125) while put sellers capture a modest ~9.6% total premium ($12 on $125) equating to ~5% annualized over ~1.9 years; market-makers and volatility sellers take the other side but face large tail risk.

Risk assessment: A rough Black‑Scholes back‑of‑envelope implies ~32% probability ALGN < $125 by Jan‑2028 (ln(184/125)/(0.6√1.92) ≈ 0.465 → N(−0.465)≈32%), so the 5% annualized yield is small versus expected assignment risk. Near term (days–weeks) watch IV and flows around earnings; medium term (months) monitor adoption/competition and dental capex; long term (years) regulatory/clinical setbacks or loss of reimbursement are 10–20%+ tail events that would wipe out option income.

Trade implications: Avoid naked long‑dated puts for size; sellers are being paid ~5%/yr to accept a ~32% down‑move probability—poor risk/reward unless you want the stock at $113 effective cost. Prefer defined‑risk structures: cash‑secured put spreads, or buy equity with 6–9 month 25% OTM protective puts; harvest short‑dated IV if realized vol collapses >10 pts vs IV term structure.

Contrarian angle: The consensus treats the $12 premium as “easy yield” but underestimates path risk and assignment during market dislocations; long‑dated OTM put skew often reprices violently in drawdowns (2008/2020 analogs). A mispricing opportunity exists to buy protection via long‑dated put spreads if IV term‑structure is >10 pts steeper than realized vol and to sell shorter-dated calls post any IV compression.

Key Decisions for Investors

• Do NOT sell the Jan 2028 ALGN $125 naked put for size; if willing to own ALGN at $113, limit exposure to 1% of portfolio and fully cash‑secure the position (allocate $113 per share).
• If seeking income, implement a defined‑risk put credit spread: sell Jan 2028 ALGN $125 put and buy Jan 2028 $100 put (25‑point width) sized to 1–2% portfolio; this caps max loss to $25 minus net credit collected and avoids open assignment.
• If bullish on ALGN equity, establish a 1–2% long position and buy a 6–9 month 25% OTM protective put (approx. 6–9 month tenor) to limit downside; trim or hedge if ALGN 10‑day VWAP closes below $150.
• Exploit volatility dislocations: buy Jan‑2028 ALGN put spreads (e.g., $140/$110) if long‑dated IV > short‑dated IV by >10 implied vol points and cost is <6% of notional, then sell 3–6 month calls during IV compression to monetize decay.